Evidence map›Paper›PMID 34768829›Full record

ArticleInternational journal of molecular sciences2021

Forkhead Box Protein P3 (FOXP3) Represses ATF3 Transcriptional Activity.

Chiung-Min Wang, William Harry Yang, Leticia Cardoso, Ninoska Gutierrez, Richard Henry Yang, Wei-Hsiung Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Annals of medicine · 2024
    Article
  2. Article
  3. Article
  4. Transcriptional Regulation and Its Misregulation in Human Diseases.International journal of molecular sciences · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chiung-Min WangDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
William Harry YangDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Leticia CardosoDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Ninoska GutierrezDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Richard Henry YangDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.
Wei-Hsiung YangDepartment of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.ORCID 0000-0002-2904-1143
Mercer University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activating transcription factor 3 (ATF3), a transcription factor and acute stress sensor, is rapidly induced by a variety of pathophysiological signals and is essential in the complex processes in cellular stress response. FOXP3, a well-known breast and prostate tumor suppressor from the X chromosome, is a novel transcriptional repressor for several oncogenes. However, it remains unknown whether ATF3 is the target protein of FOXP3. Herein, we demonstrate that ATF3 expression is regulated by FOXP3. Firstly, we observed that overexpression of FOXP3 reduced ATF3 protein level. Moreover, knockdown FOXP3 by siRNA increased ATF3 expression. Secondly, FOXP3 dose-dependently reduced ATF3 promoter activity in the luciferase reporter assay. Since FOXP3 is regulated by post-translational modifications (PTMs), we next investigated whether PTMs affect FOXP3-mediated ATF3 expression. Interestingly, we observed that phosphorylation mutation on FOXP3 (Y342F) significantly abolished FOXP3-mediated ATF3 expression. However, other PTM mutations on FOXP3, including S418 phosphorylation, K263 acetylation and ubiquitination, and K268 acetylation and ubiquitination, did not alter FOXP3-mediated ATF3 expression. Finally, the FOXP3 binding site was found on ATF3 promoter region by deletion and mutagenesis analysis. Taken together, our results suggest that FOXP3 functions as a novel regulator of ATF3 and that this novel event may be involved in tumor development and progression.

Indexed as

Transcriptional ActivationAcetylationActivating Transcription Factor 3Binding SitesCell Line, TumorForkhead Transcription FactorsGene ExpressionHumansMutationPhosphorylationPolymorphism, Single NucleotidePromoter Regions, GeneticProtein Processing, Post-TranslationalActivating Transcription Factor 3ATF3 protein, humanForkhead Transcription FactorsFOXP3 protein, humanATF3FOXP3post-translational modificationtranscriptional activity

Identifiers

PMID34768829
PMCPMC8583784
OpenAlexW3209256360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.